Abstract
PharmAla Biotech Holdings Inc. (PharmAla" or the "Company") (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is thrilled to formally announce the launch of the Phenesafe Al platform, an Al technology stack specifically designed to derive novel substituted phenethylamine molecules for patent and subsequent development."
Key Data
-
Publication Date15 May 2025
-
Primary AuthorPharmAla Biotech
-
SourceDrug Discovery Online
-
LanguageEnglish
Click below to visit original source: